1. Leclercq IA, Da MA, Silva B, Schroyen N, VanHul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. Journal of Hepatology 2007;47(1):142-156. PMID:
17512085.
2. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver International 2006;26(10):1175-1186. PMID:
17105582.
3. Lucía F, Tamás R, Oszer R, Mercedes R. Inflammatory Mediators and Insulin Resistance in Obesity: Role of Nuclear Receptor Signaling in Macrophages. Mediators of Inflammation 2010 ID 219583.
4. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metabolism 2008;8(4):301-309. PMID:
18840360.
5. Brake DK, Smith EO, Mersmann H, Smith CW, Robker RL. ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 2006;291:C1232-C1239. PMID:
16807303.
6. Robker RL, Collins RG, Beaudet AL, Mersmann HJ, Smith CW. Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res 2004;12:936-940. PMID:
15229332.
7. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005;16:1711-1722. PMID:
15857924.
8. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011;5:607-615. PMID:
21818123.
9. Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun 2011;25:811-816. PMID:
21354469.
10. Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-129. PMID:
19827166.
11. Sreenivasa BC, Alexander G, Kalyani B, Pandey R, Rastogi PA, Choudhuri G. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2006;21:191-198. PMID:
16706832.
12. Lee YR, Jeong SH, Park HG, Jeong JH, Lee WL. The effects of either resveratrol supplementation or aerobic exercise training combined with a low fat diet on the molecules of adipogenesis and adipocyte inflammation in high fat diet induced mice. JENB 2013;17(1):15-25.
13. Kawanishi N, Yano H, Mizokami T, Takahashi M, Oyanagi E, Suzuki K. Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice. Brain Behavior and Immunity 2012;26:931-941.
14. Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term lipid outcomes a systematic review. Obes Rev 2004;5:43-50. PMID:
14969506.
15. Frémont L. Biological effects of resveratrol. Life Sci 2000;66:663-673. PMID:
10680575.
16. Goswami S, Das D. Resveratrol and chemoprevention. Cancer Lett 2009;284:1-6. PMID:
19261378.
17. Fremont L. Biological effects of resveratrol. Life Sci 2000;66:663-7. PMID:
10680575.
18. Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 2008;22:1367-1371. PMID:
18688788.
19. Schefer V, Talan MI. Oxygen consumption in adult and aged C57BL/6J mice during acute treadmill exercise of different intensity. Exp Gerontol 1996;31:387-392. PMID:
9415121.
20. Leonor R, Rocio M, Antonio Z, Milagros G. Long-term resveratrol administration reduces metabolic disturbances and lowders blood pressure in obese Zucker rats. Biochemical Pharmacology 2009;77:1053-1063. PMID:
19100718.
21. King GA, Fitzhugh EC, Bassett Jr DR, McLaughlin JE, Strath SJ, Swartz AM, Thompson DL. Relationship of leisure-time physical activity and occupational activity to the prevalence of obesity. Int J Obes Relat Metab Disord 2001;25:606-612. PMID:
11360141.
22. Ahn J, Kim S, Kwon D, et al. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 2008;49:1019-1028. PMID:
18930334.
23. Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term lipid outcomes a systematic review. Obes Rev 2004;5:43-50. PMID:
14969506.
24. Kawanishi N, Yano H, Yokogawa Y, Suzuki K. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high fat-diet-induced obese mice. Exercise Immunol Rev 2010;16:105-118.
25. Lagouge M, Argmann C, Grhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 2006;127:1-34.
26. Baur JA, Pearson KJ, Price NL, Jamieson NL, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on high-calorie diet. Nature 2006;444:337-342. PMID:
17086191.
27. Rocha KK, Souza GA, Ebaid GX, Seiva FR, Cataneo AC, Novelli EL. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem Toxicol 2009;47:1362-1367. PMID:
19298841.
28. Pillaed F, Van WV, Garrigue E, Moro C, Crampes F, Guiland JC, Berlan M, de Glisenzinski I, Harant I, Riviere D, Brondel L. Lipid oxidation on overweight men after exercise and food intake. Metabolism 2010;59:267-274. PMID:
19796778.
29. Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006;290:E961-E967. PMID:
16352667.
30. Bujanda L, Hijona E, Larzabal M, et al. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC astroenterol 2008;8:40-48.
31. Kobori M, Masumoto S, Akimoto Y, Takahashi Y. Dietary Quercetin alleviates diabetic symptoms and reduces streptowotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res 2009;53:859-868. PMID:
19496084.
32. Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 2008;22:1367-1371. PMID:
18688788.
33. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-964. PMID:
16322748.
34. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-184. PMID:
17200717.
35. Patsouris DL, Thapar PP, Chapman D, Olefsky J, Neels JM. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008;8:301-309. PMID:
18840360.
36. Jin X, Qin Q, Tu L, Qu J. Glucocorticoids inhibit the innate immune system of human corneal fibroblast through their suppression of toll-like receptors. Mol 2009;15:2435-2441.
37. Brake DK, Smith EO, Mersmann H, Smith CW, Robker RL. ICAM-1expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 2006;291:C1232-C1239. PMID:
16807303.
38. Robker RL, Collins RG, Beaudet AL, Mersmann HJ, Smith CW. Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res 2004;12:936-940. PMID:
15229332.
39. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005;16:1711-1722. PMID:
15857924.